Certified Diabetes Educator Practice Exam

Alanine aminotransferase (ALT) is the liver function test most commonly used to assess medication hepatotoxicity because it is primarily found in the liver and is released into the bloodstream when liver cells are damaged. An elevated level of ALT indicates liver injury and can be a direct sign of hepatotoxicity due to medications or other toxic substances that may harm liver cells.

While aspartate aminotransferase (AST) can also indicate liver damage, it is not as specific to liver tissue as ALT because it is found in other tissues, including the heart and muscles. Therefore, an increase in AST levels can occur due to various conditions unrelated to liver injury.

Lactate dehydrogenase (LDH) is another enzyme present in many tissues and does not specifically indicate liver damage; it is more commonly used to assess overall tissue damage in a variety of conditions. Alkaline phosphatase (ALP), on the other hand, primarily reflects cholestasis or bile duct obstruction rather than direct hepatocellular injury.

Thus, ALT's specificity to liver cells makes it the preferred marker for monitoring hepatotoxicity related to medications.